Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5985)	10/14/1998 12:58:00 AM
From: MARK C.	Read Replies (1) \| Respond to of 9523

Anthony, I suspect your last statement may be closer to fact than we think at the moment. Just speculation but Pfizer has been selling off its dead weight and streamlining the company for some time now. One benefit of this would be that it would make it easier to acquire and blend in an acquisition. There would be fewer overlapping divisions and would create a better fit. Just a thought. When all is said and done does anyone honestly believe Pfizer will not be higher than $100 a share next year ? There will be a fire sale going on if the drug sector takes a major hit and guess who has the cash and credit rating to capitalize on it. Pfizer management is brilliant. Do you think it was an accident that they announced a 5 billion $$$$$ repurchase before they failed to meet expectations.